Shengqiang Yu

415 Fengyang Road
Shanghai, 200003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Precision Treatment of IgA Nephropathy Based on a New Framework: Angiorenal Protection, Immunity Inhibition, B-Cell/Plasma-Cell Modulation, and Complement Inhibition.

Precision Treatment of IgA Nephropathy Based on a New Framework: Angiorenal Protection, Immunity Inhibition, B-Cell/Plasma-Cell Modulation, and Complement Inhibition.

Journal: Kidney diseases (Basel, Switzerland)

Published: December 11, 2024

The role of obinutuzumab in rituximab-refractory membranous nephropathy and minimal change disease.

The role of obinutuzumab in rituximab-refractory membranous nephropathy and minimal change disease.

Journal: Clinical kidney journal

Published: November 11, 2024

Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease.

Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease.

Journal: Kidney diseases (Basel, Switzerland)

Published: June 11, 2022

Long-Term In-Center Nocturnal Hemodialysis Improves Renal Anemia and Malnutrition and Life Quality of Older Patients with Chronic Renal Failure.

Long-Term In-Center Nocturnal Hemodialysis Improves Renal Anemia and Malnutrition and Life Quality of Older Patients with Chronic Renal Failure.

Journal: Clinical interventions in aging

Published: February 25, 2022

Nuclear Condensation of CDYL Links Histone Crotonylation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

Nuclear Condensation of CDYL Links Histone Crotonylation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

Journal: Journal of the American Society of Nephrology : JASN

Published: November 20, 2021

Xper computed tomography-guided translumbar inferior vena cava catheterization for long-term hemodialysis: A case report and literature review.

Xper computed tomography-guided translumbar inferior vena cava catheterization for long-term hemodialysis: A case report and literature review.

Journal: Seminars in dialysis

Published: April 20, 2021

PKD2 gene variants in Chinese patients with autosomal dominant polycystic kidney disease.

PKD2 gene variants in Chinese patients with autosomal dominant polycystic kidney disease.

Journal: Clinical genetics

Published: March 31, 2021

Treatment Options for Kidney Failure in China: Conservative Management More Than Dialysis?

Treatment Options for Kidney Failure in China: Conservative Management More Than Dialysis?

Journal: Kidney medicine

Published: October 05, 2020

Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis.

Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis.

Journal: Clinical kidney journal

Published: May 29, 2020

Nocturnal Hemodialysis Compared with Conventional Dialysis for End-Stage Renal Disease Treatment in Polycystic Kidney Disease Patients.

Nocturnal Hemodialysis Compared with Conventional Dialysis for End-Stage Renal Disease Treatment in Polycystic Kidney Disease Patients.

Journal: Blood purification

Published: August 31, 2019

Is urinary oxalate inversely correlated with glomerular filtration rate in chronic kidney disease?

Is urinary oxalate inversely correlated with glomerular filtration rate in chronic kidney disease?

Journal: Renal failure

Published: June 05, 2019

Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.

Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.

Journal: Trials

Published: January 09, 2019

Showing 1-12 of 28

Last Updated: 09/26/2026